What investment stages does HealthCap focus on?

Stockholm-based life sciences VC investing in precision medicine and breakthrough therapeutics. Over €800M raised across nine funds with a proven IPO and trade sale track record.

Typical check size

From €3M

Fund size: €200M (Fund IX, 2024)

Browse similar check sizes →

Portfolio highlights

Calliditas Therapeutics - kidney disease (acquired by Asahi Kasei for $3.6B)

Hansa Biopharma - enzyme immunotherapy for transplants

Oncopeptides - oncology peptide-drug conjugates

Contact

healthcap.eu

Sweden

Research with AI

Learn more about HealthCap using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what HealthCap and similar investors look for:

Biotech pitch guide

More investors in Sweden

Aggregate Media Alfvén & Didrikson Aligned All Generation Ventures View all in Sweden

Related resources

Series A fundraising guide Series A pitch deck guide Series B fundraising guide Glossary: Term sheet Glossary: Cap table What investors look for

Fundraising in Sweden

Tips, programs, and cultural notes

More Biotech investors

Abingworth ACF Investors Ahren Innovation Capital Almi Invest GreenTech View all Biotech investors

Venture capital

Sweden

HealthCap

Investment focus

Sectors

Biotech

Investment stages

Series A

Series B

Geographic focus

Europe

Investment thesis

Stockholm-based life sciences VC investing in precision medicine and breakthrough therapeutics. Over €800M raised across nine funds with a proven IPO and trade sale track record.